Does red light therapy actually grow hair?
For pattern hair loss, the short answer is yes, modestly. Low-level light therapy (LLLT), delivered by lasers or LEDs in the red range, has been tested in sham-controlled trials where neither the patient nor the assessor knew who had the real device. That's a higher bar than most hair products ever clear.
A 2017 meta-analysis in the Journal of the American Academy of Dermatology pooled only good or fair quality randomised trials and found light therapy in men beat placebo, alongside minoxidil and finasteride. The authors concluded all three are effective for promoting hair growth in men with androgenetic alopecia.
The most recent large review, a 2025 meta-analysis in Dermatologic Surgery, included 38 studies and 3,098 patients, nearly all with androgenetic alopecia. Hair density increased significantly against placebo, both before 20 weeks and after. The catch is heterogeneity: the studies used very different devices, doses and schedules, so the pooled number is an average over a lot of variation.
A 2026 review of energy-based devices put the pooled gain from light therapy at about 18.6 hairs per square centimetre over sham, plus a small increase in shaft thickness. Many people would see that as thicker hair. Few would call it a full head of hair.
What the individual trials found
Two sets of trials are worth knowing because they're the template most devices are tested against.
The HairMax LaserComb trials randomised 269 men and women to a laser comb or a sham device, three times a week for 26 weeks. Terminal hair counts rose by roughly 18 to 26 hairs per square centimetre in the treated groups, against 1.6 to 9.4 with sham. No serious adverse events were reported.
The Lanzafame helmet trials used a cap with 655 nm lasers and LEDs, every other day for 16 weeks. In 44 men the treated group showed a 35 to 39% greater increase in hair counts than placebo. In 47 women the gap was 37%. Both trials were small, and the effect was measured on a small tattooed patch of scalp rather than across the whole head.
Note what these trials had in common: consistent use over four to six months, people with active thinning instead of long-bald areas, and skin types I to IV. Those conditions shape who should expect a result.
Who responds, and who probably won't
Light therapy appears to work on follicles that are shrinking but still alive. It nudges more of them into the growth phase and thickens the hairs they make. It can't restart a follicle that's gone, which is why smooth, shiny bald scalp is a poor candidate.
- Likely candidates: men with early to moderate thinning (Norwood IIa to V) and women with diffuse thinning at the part (Ludwig I to II), as enrolled in the main trials.
- Uncertain: darker skin types (Fitzpatrick V and VI) were excluded from most trials, and Celluma's RESTORE clearance is for types I to IV.
- Unlikely to help: long-established baldness, scarring alopecias, and hair loss from a medical cause such as thyroid disease or iron deficiency, which needs a diagnosis first.
- Little studied: alopecia areata and telogen effluvium. The 2025 meta-analysis found too few studies to pool.
A realistic timeline
Hair grows about a centimetre a month, and a follicle moved into the growth phase needs time before the new hair is long enough to see. That's why trials measure at 16 and 26 weeks.
Some people notice more shedding in the first one or two months, as resting hairs are pushed out by new growth. Dermatologists see the same thing with minoxidil. By three to four months you may see finer new hairs along the part or crown. Six months is the fair point to judge it, with photos taken in the same light at the start.
Gains last only while you keep going. Androgenetic alopecia is progressive, and no trial suggests light therapy changes that. Treat it like minoxidil: a maintenance habit, several sessions a week, for as long as you want the result.
Which Celluma devices are cleared for hair
Celluma's hair clearance is K211038, granted in June 2021 to the Celluma RESTORE. It covers treating androgenetic alopecia and promoting hair growth in men (Norwood IIa to V) and women (Ludwig I-1 to II-2) with Fitzpatrick skin types I to IV, over the counter.
Celluma devices use 640 nm red and 880 nm near-infrared light, plus 465 nm blue for acne modes, from a flexible panel that drapes over the scalp.
Celluma lists a hair mode on five devices. Prices were checked on celluma.com on 18 November 2026:
- RESTORE, $1,195: hair, aging skin and pain. See the RESTORE review.
- MYSTIQUE LED Mask, $995: face and scalp together, so hair can run alongside a skin mode in one 30-minute session. See the MYSTIQUE review.
- NOVA, $1,595: all five modes in a compact battery panel. See the NOVA review.
- CONTOUR PLUS, from $2,995, and ELITE, from $3,995: multi-panel systems with a hair mode, mainly bought by clinics.
Should you pick a Celluma for hair?
We haven't used these devices; this section is built from specs, the FDA records and published data. Celluma hasn't published its own sham-controlled hair trial that we could find, so the evidence above comes from other red light devices. The clearance tells you the FDA accepted the RESTORE as equivalent to earlier hair devices; it makes no claim that it beat them.
Where Celluma stands out is versatility. A RESTORE also treats facial wrinkles and joint pain, which a hair-only cap can't.
If hair is your only goal, a dedicated laser cap or helmet may cover the scalp more evenly for less money. If you'd use the same device for your face, the RESTORE or MYSTIQUE makes more sense. Our Celluma review and which Celluma is best for home compare the full range.
On price: Celluma's Cyber Sale takes up to 15% off until 2 December, applied at checkout, and HSA/FSA checkout can save more. The Celluma discount code page and Celluma Black Friday tracker list what's live.
Alternatives worth weighing
Light therapy is a reasonable first step for people who don't want medication, but it isn't the strongest option. Talk to a dermatologist before committing to months of any of these.
- Minoxidil: FDA-approved, cheap, with the most trial data for both men and women. One 2025 meta-analysis found adding light therapy to minoxidil gave no extra gain; the 2026 review found the opposite.
- Finasteride: an FDA-approved prescription pill for men, which slows the hormonal driver of pattern loss.
- Other cleared light devices: HairMax, Capillus and iRestore laser devices, and CurrentBody's LED hair helmets, all have 510(k) clearances in the FDA database. Our best at-home red light therapy comparison covers the wider device field, and if your face matters as much as your hairline, see best red light therapy for face and our Omnilux and Celluma comparison.
- Peptides: copper peptides and others are being studied for hair, mostly in lab and small studies. See peptides for hair growth for where that research stands.
